Prolonged or Continuous Infusion of IV Antibiotics as Initial Treatment Strategy

참고문헌 (10)

1. Craig WA, "Killing and regrowth of bacteria in vitro:a review", Scand J Infect Dis Suppl, 74, pp.63~70 (1990)
2. Craig WA, "Continuous infusion of beta-lactam antibiotics", Antimicrob Agents Chemother, 36, pp.2577~2583 (1992)
3. Drusano GL, "Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'", Nat Rev Microbiol, 2, pp.289~300 (2004)
4. Drusano GL, "Use of preclinical data for selection of a phase II", III dose for evernimicin and identification of a preclinical MIC breakpoint, 2001, pp.45, 13~22
5. Mouton JW, "Use of Monte Carlo simulations to select therapeutic doses and provisional breakpoints of BAL9141", Antimicrob Agents Chemother, 48, pp.1713~1718 (2004)
6. Ariano RE, "Pharmacokinetics and pharmacodynamics of meropenem in febrile neutropenic patients with bacteremia", Ann Pharmacother, 39, pp.32~38 (2005)
7. Zelenitsky S, "Evaluating ciprofloxacin dosing for Pseudomonas aeruginosa infection by using clinical outcome-based Monte Carlo simulations", Antimicrob Agents Chemother, 49, pp.4009~4014 (2005)
8. Lodise TP Jr, "Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy", Clin Infect Dis, 44, pp.357~363 (2007)
9. Nicolau DP, "Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia", Int J Antimicrob Agents, 17, pp.497~504 (2001)
10. Ashima Lal, "Prolonged versus Intermittent Infusion of β-Lactams for the Treatment of Nosocomial Pneumonia: A Meta- Analysis", Infection and Chemotherapy, 48(2), pp.81~90 (2016), 대한감염학회

관련 논문AI추천